Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Mitochondrial CIV Assembly WP4922,-0.528658635,-2.080184648,0,0.004935834,0.02,13/35,23.20%,COX5B;PET100;COX14;COX7C;COX5A;CMC1;COX20;COX6A1;SCO2;COX6B1;COX7B;SMIM20;COX4I1
prerank,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.627312797,1.810208019,0.013513514,0.259617654,0.17,Sep-74,23.55%,ACTG1;ACTN1;CTNNB1;ITGB4;DSG2;LMNA;ATP2A2;ITGB1;ACTN4
prerank,Tumor suppressor activity of SMARCB1 WP4204,0.638577267,1.805069344,0,0.141609629,0.19,31-Jul,9.64%,H3F3B;ACTL6A;SMARCD2;ARID1A;CDKN2A;SMARCC1;SMARCE1
prerank,Endoderm differentiation WP2853,0.481100893,1.761906605,0,0.200613642,0.32,21/141,31.01%,APP;RTF1;CDYL;CTNNB1;PIAS1;CAND1;PABPC1;CTR9;PHF6;DKK1;CUL4B;BPTF;LAMC1;PARP8;AHDC1;FOXA1;MAP2K3;STAT1;LRPPRC;CTBP2;AEBP2
prerank,Pathogenic Escherichia coli infection WP2272,0.57055549,1.75526502,0,0.159310833,0.34,14/55,23.47%,NCK1;ACTG1;YWHAZ;ROCK1;CTNNB1;TUBA4A;ARPC3;ARPC2;ARPC1B;YWHAQ;CDH1;FYN;ITGB1;ARPC5
prerank,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.539116382,1.746050462,0,0.136889308,0.37,14/47,31.54%,MAP4K5;ACTG1;CTNNB1;TEAD1;STK3;ITGB4;YWHAQ;MAPK8;CDH1;ITGB1;PAK1;TEAD2;ACTB;SAV1
prerank,Focal Adhesion WP306,0.43656615,1.733757677,0,0.123908426,0.39,37/198,23.87%,LAMA3;MYL12B;CAV1;SHC1;MYL12A;AKT2;ACTG1;ERBB2;ARHGAP35;PPP1CB;FN1;DIAPH1;ROCK1;ACTN1;CTNNB1;LAMA5;PPP1R12A;FLNA;MAPK3;ARHGAP5;PDGFB;SOS1;ITGB4;MAPK8;LAMC1;CRK;FYN;PIK3CB;IGF1R;THBS1;RAP1B;AKT1;GRB2;PTK2;ITGB1;ACTN4;VCL
prerank,Ebola Virus Pathway on Host WP4217,0.449404553,1.697082584,0,0.158467919,0.47,26/129,26.91%,CAV1;RHOC;ACTG1;ADAM17;RAB5A;ACTN1;RAB7A;FLNA;MAPK3;VPS41;AXL;TSG101;TBK1;IRF3;PIK3CB;IGF1R;NPC1;AKT1;PRKRA;CLTC;ITGB1;ACTN4;KPNA1;PAK1;RFC1;STAT1
prerank,Exercise-induced Circadian Regulation WP410,0.572234718,1.685031131,0,0.159310833,0.52,Jul-48,15.57%,EIF4G2;VAPA;TAB2;NCOA4;NCKAP1;UGP2;SUMO1
prerank,TGF-beta Signaling Pathway WP366,0.422192569,1.66868711,0,0.154721632,0.55,27/132,23.18%,CAV1;SHC1;APP;JUND;SKP1;FN1;ROCK1;PIAS1;SIN3A;TGFBR2;NUP153;SOS1;ITGB4;MAP2K4;TGIF1;WWP1;MAPK8;SUMO1;MAPK14;THBS1;AKT1;GRB2;PPM1A;PTK2;YAP1;ATF3;ITGB1
prerank,EGF/EGFR signaling pathway WP437,0.417773411,1.661125452,0,0.151050271,0.58,39/162,28.69%,CAV1;SHC1;PTPN12;AP2M1;JUND;NCK1;ERBB2;USP8;RAB5A;ROCK1;RASA1;STAMBP;AP2B1;ASAP1;SOS1;CFL1;PRKCI;MAPK8;INPPL1;STMN1;CRK;PXDN;RPS6KA3;JAK1;MAPK14;IQSEC1;EPS8;RICTOR;AKT1;GRB2;PLSCR1;ATXN2;PTK2;AP2S1;PAK1;MAP3K2;STAT1;RALBP1;ITCH
prerank,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.478401472,1.620336875,0.023529412,0.213487244,0.72,16/72,26.60%,NCK1;CTNNB1;LAMA5;MYO1E;ITGB4;YWHAQ;DKK1;FYN;CD2AP;AKT1;PTK2;ITGB1;ACTN4;VCL;LIMS1;SMARCAL1
prerank,Pathways affected in adenoid cystic carcinoma WP3651,0.493438013,1.615982184,0,0.202580442,0.73,Nov-65,19.80%,MORF4L1;ERBB2;ARID1A;DTX4;SMARCE1;TLK1;SETD2;NSD1;SRCAP;AKT1;KANSL1
prerank,Parkinson's disease pathway WP2371,0.595413717,1.608122811,0.042253521,0.204244658,0.76,Sep-38,25.98%,UBB;UCHL1;CASP2;UBE2J2;UBE2G1;MAPK14;ATXN2;PARK7;HTRA2
prerank,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.474066378,1.603858661,0.011904762,0.201456556,0.76,18/68,25.08%,IKBKG;NCK1;ERBB2;FN1;RASA1;CTNNB1;MAPK3;SOS1;MAPK8;STMN1;CRK;MAPK14;AKT1;GRB2;PTK2;YAP1;ITGB1;PAK1
prerank,Regulation of Actin Cytoskeleton WP51,0.416246593,1.59259887,0.011904762,0.210054284,0.78,25/150,25.08%,RRAS2;ACTG1;ARHGAP35;FN1;DIAPH1;ROCK1;ACTN1;BAIAP2;NCKAP1;RDX;PPP1R12A;MAPK3;PDGFB;SOS1;CFL1;PIK3C3;CRK;PIK3CB;ENAH;WASF1;PTK2;ARPC5;GNA12;VCL;PAK1
prerank,Circadian rhythm related genes WP3594,0.418475009,1.58155529,0,0.215364645,0.81,24/201,24.83%,NAMPT;HNRNPU;DDX5;CSNK1D;JUND;NONO;SKP1;PRKAA1;MAGED1;AHR;PPP1CB;ARNTL2;SIN3A;GFPT1;CSNK1E;THRAP3;MAPK8;AHCY;CCAR2;SETX;KDM5A;CDK4;OGT;NCOR1
prerank,Corticotropin-releasing hormone signaling pathway WP2355,0.471245179,1.577603115,0,0.20894362,0.81,13/93,21.68%,JUND;GNAS;TRIM28;CTNNB1;MAPK3;PRKCI;ECE1;MAPK8;MAPK14;HSP90AA1;RAP1B;AKT1;PTK2
prerank,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.45886405,1.57600746,0.022988506,0.198646841,0.82,16/66,28.03%,SHC1;NCK1;ERBB2;FN1;CTNNB1;DVL1;DAAM1;SOS1;MAP2K4;MAPK8;AKT1;GRB2;PTK2;PAK1;ACTR2;FZD6
prerank,Regulation of Microtubule Cytoskeleton WP2038,0.5382324,1.567053794,0.053333333,0.199992547,0.83,15/46,36.22%,DIAPH1;ROCK1;DVL1;STMN1;MARK2;TRIO;AKT1;PRKACA;MAP1B;PTPRA;CLIP1;PAK1;RAC1;CFL2;PHLDB2
prerank,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.502715079,1.562764255,0,0.196483361,0.83,14/46,26.27%,CSNK2A1;EIF4A1;EIF4G1;AKT2;MAPK3;MAP2K4;EIF4A2;MAPK8;PIK3CB;MAPK14;AKT1;PRKACA;EIF4G3;MAP2K3
prerank,Translation Factors WP107,0.458771775,1.553946827,0.011627907,0.201175585,0.84,Nov-52,13.68%,EEF1D;EIF4A1;EIF4G1;PAIP1;EEF1A1;EIF3CL;EIF3E;EIF3H;PABPC1;EIF5;EIF4A2
prerank,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.41857666,1.553599046,0.010989011,0.19256764,0.84,25/132,28.23%,SHC1;MAP4K5;AKT2;PRKAA1;MAPK3;MAP3K13;SOS1;MAP2K4;PIK3C3;MAPK8;CAP1;CRK;RPS6KA3;PIK3CB;MAPK14;RICTOR;AKT1;MINK1;MAPKAP1;MAP3K2;EXOC7;MAP2K3;MAP3K14;PIK3C2A;FBP1
prerank,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.518843719,1.540144868,0.023809524,0.210875209,0.87,14/62,27.26%,IKBKG;NCK1;AHSA1;DLG1;MAPK3;SOS1;FYN;BCL10;AKT1;GRB2;CDK4;PAK1;CALM1;MAP3K14
prerank,Hepatitis B infection WP4666,0.416409889,1.536392551,0.022988506,0.206514043,0.88,25/152,26.93%,DDX3X;IKBKG;AKT2;YWHAZ;TAB2;IFNAR1;MAPK3;TGFBR2;SOS1;MAP2K4;TBK1;YWHAQ;MAPK8;IRF3;PIK3CB;JAK1;MAPK14;AKT1;GRB2;BID;YWHAB;ATP6AP1;MAP2K3;STAT1;TYK2
prerank,Alpha 6 Beta 4 signaling pathway WP244,0.538881067,1.528265428,0.037974684,0.205805995,0.89,Nov-33,21.68%,LAMA3;SHC1;LAMA5;MAPK3;SOS1;ITGB4;LAMC1;MAPK14;AKT1;GRB2;PTK2
prerank,Pathways Regulating Hippo Signaling WP4540,0.457104324,1.528046107,0.025641026,0.19789038,0.89,17/98,42.28%,GNAS;PRKAA1;CTNNB1;TEAD1;STK3;PRKCI;CDH1;IGF1R;PRKACA;PRKD3;TEAD2;MET;RAC1;EGFR;SMAD3;TAZ;PRKAR1A
prerank,Acute viral myocarditis WP4298,0.455319721,1.523089134,0.047058824,0.197991241,0.9,15/86,19.92%,CAV1;EIF4G2;EIF4G1;CD55;BNIP2;RASA1;CASP2;MAPK3;SOS1;PABPC1;JKAMP;FYN;JAK1;AKT1;BID
prerank,VEGFA-VEGFR2 Signaling Pathway WP3888,0.353044711,1.505186022,0,0.225901076,0.94,83/432,30.41%,CAV1;EIF4G2;SHC1;RACK1;EIF4G1;BRD4;PRDX6;NCK1;SET;MYO1C;RHOC;ACTG1;FLII;RAB11A;PRKAA1;P4HB;NAP1L1;FAM120A;MMP14;RAB5A;FN1;ROCK1;CTNNB1;EIF3H;MAPK3;TPM3;AFDN;TMOD3;RBM39;PABPC1;MAP2K4;CFL1;GRSF1;PRKCI;DNAJB4;SPIRE1;MAPK8;DKK1;CRK;CTNND1;FYN;MAPK14;EWSR1;HSP90AA1;LDHA;RAP1B;RICTOR;AKT1;PRKRA;GRB2;CNP;SSR3;WASF1;DHX36;NDRG1;PTK2;CLTC;ACP1;TRAF3IP2;INPP4B;ITGB1;AP2S1;SLC25A11;VCL;GATA2;MAPKAP1;PAK1;MAP2K3;YWHAE;CRIP2;STAT1;NUMB;TKT;EIF2A;FBXW11;ITCH;OCRL;PRRC2C;RAP1A;HYOU1;ACOT9;PPP3CA;PLOD3
prerank,Prolactin Signaling Pathway WP2037,0.435586909,1.50419585,0.011363636,0.218925232,0.94,18/76,26.91%,SHC1;CTSD;ERBB2;YWHAZ;FLNA;MAPK3;SOS1;MAPK8;FYN;PIK3CB;JAK1;MAPK14;AKT1;GRB2;PTK2;ITGB1;PAK1;STAT1
prerank,Oncostatin M Signaling Pathway WP2374,0.45232969,1.503726705,0.033707865,0.211627724,0.94,14/65,26.93%,SHC1;JUND;MAPK3;SOS1;MAPK8;IL6ST;JAK1;MAPK14;RICTOR;AKT1;GRB2;HIF1A;STAT1;TYK2
prerank,Insulin Signaling WP481,0.404164329,1.498313436,0.032608696,0.215079142,0.94,27/160,27.79%,SHC1;MAP4K5;AKT2;MYO1C;PRKAA1;MAPK3;EHD1;MAP3K13;SOS1;MAP2K4;PRKCI;PIK3C3;MAPK8;INPPL1;CAP1;CRK;RPS6KA3;PIK3CB;MAPK14;IGF1R;AKT1;GRB2;MINK1;MAP3K2;MAP2K3;MAP3K14;PIK3C2A
prerank,Male infertility WP4673,0.417682772,1.498248921,0.048192771,0.208357918,0.94,14/146,34.50%,CLU;USP8;AHR;CXXC1;CDK9;THBS1;PEMT;KDM3A;XRCC4;UBE2B;RFC1;MTRR;ABLIM1;CDC42BPA
prerank,Hippo-Merlin Signaling Dysregulation WP4541,0.432436989,1.491910181,0.025974026,0.212772044,0.94,23/120,42.28%,PPP1CB;CTNNB1;PPP1R12A;TEAD1;STK3;ITGB4;CDH1;IGF1R;PRKACA;PTK2;ITGB1;PAK1;NRAS;CUL4A;TEAD2;SAV1;MET;DCAF1;EGFR;CCND1;PPP1CA;TAZ;PRKAR1A
prerank,Complement system WP2806,0.522977214,1.488663782,0.037974684,0.212414444,0.95,Aug-97,20.73%,C3;CD55;LAMA5;CSNK1A1;CD59;LAMC1;THBS1;PRKACA
prerank,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.470254248,1.476196844,0.037037037,0.226575407,0.96,Sep-86,16.28%,CSNK2A1;RYK;MTDH;CTNNB1;DVL1;CSNK1E;CSNK1A1;DKK1;DVL3
prerank,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.452347913,1.472585236,0.048780488,0.224215247,0.96,14/94,30.24%,HNRNPU;CSNK2A1;RYK;CTNNB1;DVL1;CSNK1E;CSNK1A1;DKK1;DVL3;HNRNPK;ATF3;SENP2;FZD6;CTBP2
prerank,Mitochondrial complex I assembly model OXPHOS system WP4324,-0.349595843,-1.47095002,0,0.186327739,0.65,Aug-56,13.06%,NDUFA13;NDUFA1;ECSIT;NDUFB7;NDUFB2;NDUFA2;DMAC2;DMAC1
prerank,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.392132735,1.470390623,0.021978022,0.221344781,0.96,20/160,20.01%,SHC1;AKT2;FN1;CLDN7;CTNNB1;MAPK3;CRB3;CTDSP1;TJP1;TGFBR2;SOS1;MAP2K4;MAPK8;RBPJ;CDH1;PIK3CB;MAPK14;AKT1;GRB2;RBBP4
prerank,PDGFR-beta pathway WP3972,0.518831115,1.457174202,0.051282051,0.238189881,0.98,29-Aug,19.36%,SHC1;RASA1;MAPK3;SOS1;MAP2K4;MAPK8;JAK1;GRB2
prerank,T-cell receptor (TCR) signaling pathway WP69,0.491801364,1.456347494,0.036585366,0.232990202,0.98,15/90,27.84%,SHC1;IKBKG;NCK1;MAPK3;SOS1;MAPK8;CRK;FYN;MAPK14;BCL10;AKT1;GRB2;PAK1;MAP3K14;RIPK2
prerank,Ciliary landscape WP4352,0.357216411,1.456304413,0.010989011,0.227165447,0.98,49/216,37.25%,DDX5;CNOT1;UBE2H;COPS2;CTNNB1;DYNC1I2;EXOC5;HSPB11;AIMP1;ARFGAP3;COPS7B;MYL6B;SMC4;COPS6;EHBP1;PSMD8;UBE2D2;IFT57;RAB14;RANBP9;DVL3;NDUFA5;CNOT9;EXOC3;TIPRL;YAP1;PSMC6;TRAF3IP1;DYNC1H1;WDR26;CALM1;HTRA2;EXOC7;PAFAH1B1;COPS4;IFT52;LRPPRC;CTBP2;HDAC2;MAPRE2;RHBDD2;DNPEP;IFT74;RAC1;COPS3;LZTFL1;YPEL5;COPS7A;TNKS1BP1
prerank,B Cell Receptor Signaling Pathway WP23,0.450894813,1.446496838,0.024691358,0.237742996,0.98,14/97,19.36%,SHC1;IKBKG;NCK1;GTF2I;CD81;SOS1;PTPN18;MAPK8;CRK;FYN;MAPK14;BCL10;AKT1;GRB2
prerank,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.422074773,1.440516379,0.082352941,0.244726165,0.98,14/84,19.36%,SHC1;RRAS2;AKT2;ERBB2;MAPK3;PDGFB;SOS1;AXL;ERBB3;PIK3CB;JAK1;IGF1R;AKT1;GRB2
prerank,IL-3 signaling pathway WP286,0.473167373,1.437484196,0.048192771,0.245072479,0.98,Nov-49,20.73%,SHC1;MAPK3;SOS1;YWHAQ;MAPK8;FYN;JAK1;AKT1;GRB2;YWHAB;PRKACA
prerank,Small cell lung cancer WP4658,0.414364614,1.43459967,0.070588235,0.247012251,0.98,14/96,24.11%,LAMA3;IKBKG;AKT2;SKP1;FN1;LAMA5;LAMC1;PIK3CB;AKT1;BID;PTK2;ITGB1;CDK4;TRAF4
prerank,mRNA Processing WP411,0.373744887,1.431390558,0,0.248341332,0.98,44/126,38.33%,HNRNPU;HNRNPH1;NONO;PABPN1;SNRPA;SRSF3;PRPF4B;SF3B1;RNPS1;RBM39;SF3A1;DHX15;HNRNPL;SNRPD3;PTBP1;SNRNP70;HNRNPK;TXNL4A;FUS;RNMT;PRPF40A;CSTF1;PRMT2;HNRNPC;CLK1;SNRPE;CPSF2;SRRM1;NXF1;SNU13;CLK3;TMED10;SRSF10;PRPF8;SPOP;RBM5;PAPOLA;SRSF2;SFPQ;SRSF5;U2AF2;CDC40;SF3A3;PRMT1
prerank,Glycogen Synthesis and Degradation WP500,0.52206943,1.426091621,0.068493151,0.25448687,0.98,Aug-40,27.37%,PPP2R5C;PPP2R5E;PPP2R2A;UGP2;PPP2R5A;PYGB;CALM1;AGL
prerank,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.41188841,1.425332675,0.081395349,0.250578741,0.98,17/84,27.26%,IKBKG;AKT2;ROCK1;CTNNB1;DVL1;MAPK3;CDK9;MAP2K4;MAPK8;IL6ST;PIK3CB;MAPK14;IGF1R;AKT1;CALM1;MAP2K3;MAP3K14
prerank,Myometrial relaxation and contraction pathways WP289,0.40100572,1.412891838,0.060240964,0.267484856,0.99,14/156,26.34%,DGKZ;GNAS;ACTG1;GABPA;IGFBP6;YWHAZ;CALD1;YWHAQ;ATP2A2;YWHAB;PRKACA;ATF3;CALM1;YWHAE
prerank,MAPK Cascade WP422,0.484070922,1.410789556,0.1,0.265397639,1,Sep-33,28.89%,LAMTOR3;MAPK3;SOS1;MAP2K4;MAPK14;GRB2;MAP3K2;MAP2K3;NRAS
prerank,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.393330033,1.395776945,0.084210526,0.291243805,1,18/144,19.36%,SHC1;RACK1;IKBKG;CSNK2A1;NCK1;PRKAA1;ADAM17;CTNNB1;DLG1;MAPK3;CFL1;MAPK8;RANBP9;RPS6KA3;FYN;MAPK14;AKT1;GRB2
prerank,DNA damage response (only ATM dependent) WP710,0.409423729,1.394978261,0.072289157,0.287384248,1,15/110,19.36%,SHC1;AKT2;ERBB2;PPP2R5C;CDKN2A;CTNNB1;PPP2R5E;DVL1;SOS1;PIK3C3;MAPK8;DVL3;PIK3CB;AKT1;GRB2
prerank,Lipid Metabolism Pathway WP3965,0.503727736,1.392996549,0.123287671,0.28616946,1,29-May,20.73%,AKT2;PRKAA1;ACLY;AKT1;PRKACA
prerank,PI3K-Akt signaling pathway WP4172,0.349229986,1.392707543,0.063829787,0.281438006,1,29/340,24.08%,LAMA3;IKBKG;AKT2;COL6A1;PRKAA1;PPP2R5C;FN1;LAMA5;PPP2R5E;PPP2R2A;IFNAR1;MAPK3;PDGFB;HSP90B1;SOS1;ITGB4;PPP2R5A;LAMC1;PIK3CB;JAK1;IGF1R;THBS1;HSP90AA1;AKT1;GRB2;PTK2;KITLG;ITGB1;CDK4
prerank,Head and Neck Squamous Cell Carcinoma WP4674,0.408474332,1.391549274,0.105882353,0.279067125,1,16/73,28.89%,AKT2;ERBB2;PRKAA1;CUL3;CDKN2A;FKBP1A;CTNNB1;TGFBR2;PIK3CB;IGF1R;RICTOR;AKT1;CDK4;MAPKAP1;NUMB;NRAS
prerank,Wnt Signaling Pathway WP363,0.426145771,1.381133155,0.075,0.293947261,1,Sep-52,19.26%,CSNK1D;RYK;CTNNB1;DVL1;CSNK1E;CSNK1A1;MAPK8;DVL3;AKT1
prerank,IL-2 signaling pathway WP49,0.489541675,1.378601829,0.05952381,0.293123504,1,Jul-42,19.36%,SHC1;MAPK3;SOS1;FYN;JAK1;AKT1;GRB2
prerank,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.475138767,1.378465386,0.057142857,0.288395049,1,Aug-58,18.08%,FKBP1A;CTNNB1;MAPK3;TGFBR2;LTBP3;TGIF1;JAK1;THBS1
prerank,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.488120812,1.377342914,0.066666667,0.285457342,1,Nov-35,33.90%,TEAD1;STK3;YWHAQ;MAPK14;NDRG1;YAP1;MOB1A;RAP1A;TEAD2;SAV1;RAC1
prerank,Interferon type I signaling pathways WP585,0.450620874,1.376236711,0.077922078,0.282619218,1,15/54,33.90%,RACK1;EIF4A1;PIAS1;IFNAR1;CRK;FYN;JAK1;MAPK14;MAPKAP1;MAP2K3;STAT1;TYK2;RAP1A;EIF4B;RAC1
prerank,Kit receptor signaling pathway WP304,0.42981147,1.375103144,0.101123596,0.279088978,1,Nov-59,22.12%,SHC1;MAPK3;SOS1;MAPK8;CRK;RPS6KA3;FYN;MAPK14;AKT1;GRB2;KITLG
prerank,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.4604857,1.373642556,0.101265823,0.276448307,1,Oct-55,40.01%,NAP1L1;CTNNB1;CSNK1A1;LMNA;CDK4;FNTA;ACTB;TARBP2;TGFB2;SMAD3
prerank,Regulatory circuits of the STAT3 signaling pathway WP4538,0.431899134,1.371439266,0.047619048,0.276557516,1,Nov-78,26.93%,TRIM28;IFNAR1;MAPK3;MAPK8;STMN1;IL6ST;JAK1;MAPK14;RICTOR;MAPKAP1;TYK2
prerank,Wnt signaling WP428,0.397088333,1.364949612,0.038961039,0.285841659,1,10/115,16.28%,CSNK2A1;RYK;CTNNB1;DVL1;DAAM1;CSNK1E;CSNK1A1;MAPK8;DKK1;DVL3
prerank,ErbB signaling pathway WP673,0.383101693,1.34913701,0.072289157,0.304608213,1,14/91,21.68%,SHC1;NCK1;AKT2;ERBB2;MAPK3;SOS1;MAP2K4;MAPK8;ERBB3;CRK;PIK3CB;AKT1;GRB2;PTK2
prerank,Wnt signaling pathway and pluripotency WP399,0.403236651,1.347568979,0.12,0.302282094,1,11/102,16.68%,PPP2R5C;CTNNB1;PPP2R5E;DVL1;PPP2R2A;CSNK1E;MAP2K4;PRKCI;DVL3;CTNND1;RACGAP1
prerank,Glioblastoma signaling pathways WP2261,0.389484793,1.343314473,0.130952381,0.306463264,1,20/82,37.91%,AKT2;ERBB2;CDKN2A;MAPK3;MAP2K4;PRKCI;ERBB3;PIK3CB;IGF1R;AKT1;GRB2;CDK4;MAP2K3;PIK3C2A;NRAS;NF1;MET;EGFR;PLCG1;CCND1
prerank,Aryl Hydrocarbon Receptor Pathway WP2873,0.470517779,1.342701545,0.133333333,0.302593711,1,Sep-46,35.62%,JUND;UGT1A6;AHR;MGST1;HSP90AA1;PTGES3;CAP2;CDC37;EGFR
prerank,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.441930926,1.340913665,0.092105263,0.302135251,1,13/53,27.86%,APP;JUND;YBX3;CUL5;ERBB3;THBS1;AKT1;HSPD1;PTK2;GCLC;NET1;RIPK2;SQSTM1
prerank,Nephrotic syndrome WP4758,0.459823454,1.3371522,0.133333333,0.305281629,1,Aug-45,26.60%,MYO1E;ITGB4;LMNA;YARS;CD2AP;PDSS2;ACTN4;SMARCAL1
prerank,Breast cancer pathway WP4262,0.382558854,1.337005746,0.079545455,0.301257628,1,15/154,19.36%,SHC1;CSNK2A1;AKT2;SKP1;ERBB2;CTNNB1;DVL1;MAPK3;SOS1;NBN;CSNK1A1;DVL3;IGF1R;AKT1;GRB2
prerank,MECP2 and Associated Rett Syndrome WP3584,0.470581425,1.336708014,0.074626866,0.297845606,1,Nov-72,34.12%,HNRNPH1;SIN3A;SP3;IGF1R;FUS;AKT1;CNP;FUT8;NCOR1;NF1;UBE3A
prerank,Toll-like Receptor Signaling Pathway WP75,0.410496182,1.333175486,0.12195122,0.300592663,1,12/103,19.26%,IKBKG;AKT2;TAB2;IFNAR1;MAPK3;MAP2K4;TBK1;MAPK8;IRF3;PIK3CB;MAPK14;AKT1
prerank,Metapathway biotransformation Phase I and II WP702,0.386839923,1.331856512,0.088607595,0.299223087,1,10/183,22.61%,UGT1A6;GPX3;MGST3;TPMT;MGST1;AKR1C1;AKR1C2;NAA50;GSR;COMT
prerank,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.37393054,1.32913743,0.073170732,0.298368938,1,24/69,44.22%,SEC24C;PRKAA1;SEC23B;ACLY;SEC23A;AKT1;PRKACA;MED15;SAR1B;KPNB1;YY1;NFYA;SEC24D;SAR1A;SCAP;CDK8;MVD;FDFT1;CYP51A1;FDPS;SQLE;DBI;MDH1;HMGCS1
prerank,Gastrin signaling pathway WP4659,0.363990556,1.327502002,0.103448276,0.296278814,1,21/114,25.08%,SHC1;LAMTOR3;CDKN2A;ROCK1;ANXA2;CTNNB1;MAPK3;TJP1;SOS1;YES1;MAPK8;CDH1;CRK;FYN;MAPK14;AKT1;GRB2;PRKACA;PTK2;ITGB1;PAK1
prerank,Leptin signaling pathway WP2034,0.394066254,1.327277528,0.108433735,0.292846229,1,14/76,21.68%,SHC1;IKBKG;ERBB2;PRKAA1;ROCK1;MAPK3;SOS1;MAPK8;FYN;JAK1;MAPK14;AKT1;GRB2;PTK2
prerank,Cardiac Hypertrophic Response WP2795,0.414215597,1.32530622,0.156626506,0.291648404,1,Dec-55,30.39%,IKBKG;AKT2;MAPK3;CDK9;MAP2K4;MAPK8;MAPK14;AKT1;CALM1;MAP2K3;MAP3K14;PPP3CA
prerank,22q11.2 copy number variation syndrome WP4657,0.390979832,1.32470726,0.092105263,0.288363198,1,11/131,25.59%,CUL3;PPP1CB;DROSHA;EMC10;TNPO1;MED15;TANGO2;COMT;KPNB1;NCOR1;XPO1
prerank,Thermogenesis WP4321,0.371515417,1.324039177,0.097560976,0.285459918,1,14/108,20.73%,GNAS;ACTG1;ACTL6A;PRKAA1;SMARCD2;ARID1A;SMARCC1;SMARCE1;SOS1;RPS6KA3;MAPK14;KDM3A;GRB2;PRKACA
prerank,Fragile X Syndrome  WP4549,0.371851092,1.315507035,0.112359551,0.297085202,1,24/121,30.39%,SHC1;APP;AP2M1;EIF4A1;EIF4G1;EEF1A1;DNM2;CDKN2A;AP2B1;SOS1;FYN;PIK3CB;SLC16A1;AKT1;GRB2;PRKACA;MAP1B;CLTC;AP2S1;ALDH3A2;TECR;SYNGAP1;NF1;PPP3CA
prerank,Osteoblast differentiation WP4787,0.415591525,1.306655495,0.109756098,0.307257931,1,11/118,28.03%,CTNNB1;MAPK3;PRKCI;PIK3C3;MAPK8;RBPJ;PIK3CB;MAPK14;STAT1;PIK3C2A;FZD6
prerank,RANKL/RANK signaling pathway WP2018,0.418228656,1.305427358,0.156626506,0.305381742,1,Dec-55,33.90%,IKBKG;AKT2;TAB2;MAPK3;MAPK8;MAPK14;AKT1;PTK2;STAT1;SQSTM1;LYN;RAC1
prerank,DNA IR-double strand breaks and cellular response via ATM WP3959,0.446216293,1.297432819,0.098591549,0.312650176,1,Jul-55,21.72%,ACTL6A;TRIM28;CDKN2A;STK3;NBN;BID;YAP1
prerank,TGF-beta Receptor Signaling WP560,0.443996629,1.296241203,0.136986301,0.311175922,1,Jul-54,18.08%,FKBP1A;CTNNB1;MAPK3;TGFBR2;TGIF1;JAK1;THBS1
prerank,Nuclear Receptors Meta-Pathway WP2882,0.316624298,1.29506118,0.043956044,0.309319857,1,42/319,35.62%,FTH1;JUND;UGT1A6;PRDX6;SLC5A6;ABHD2;AHR;GPX3;MGST3;GCLM;PDGFB;MGST1;TGFBR2;ACADM;KTN1;G6PD;ENC1;DNAJC15;HSP90AA1;ALAS1;GSR;ARL5B;SLC39A9;SLC7A11;ABCC3;GCLC;CDK4;SMARCA1;PTGES3;SQSTM1;NCOA6;ME1;LRRC8A;GPX2;SLC39A8;PPARA;CAP2;CPT2;CDC37;CDC42EP3;SLC6A6;EGFR
prerank,DNA IR-damage and cellular response via ATR WP4016,0.409066127,1.292186931,0.125,0.311486297,1,May-80,10.78%,IKBKG;UBE2D3;TRIM28;HUS1;NBN
prerank,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.383875302,1.287609246,0.135802469,0.316180121,1,17/158,26.34%,MAZ;YWHAZ;CTNNB1;ACADM;HSP90B1;MBD1;SP3;ECE1;YWHAQ;HADHA;YWHAB;PRKACA;HSPD1;GATA2;HIF1A;NFYA;YWHAE
prerank,Ras signaling WP4223,0.365749479,1.283592937,0.079545455,0.321840067,1,28/184,35.62%,SHC1;IKBKG;RRAS2;AKT2;RAB5A;RASA1;BRAP;MAPK3;AFDN;SOS1;MAPK8;PIK3CB;IGF1R;RAP1B;AKT1;GRB2;PRKACA;PAK1;CALM1;RALBP1;SYNGAP1;NRAS;NF1;RAP1A;MET;RAC1;RASAL2;EGFR
prerank,PDGF Pathway WP2526,0.406286389,1.281367442,0.154761905,0.322334278,1,Nov-40,26.91%,SHC1;RASA1;MAPK3;PDGFB;SOS1;MAP2K4;MAPK8;JAK1;GRB2;PAK1;STAT1
prerank,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.325846264,1.277526855,0.126315789,0.325439908,1,40/303,35.97%,LAMA3;IKBKG;AKT2;PRKAA1;PPP2R5C;FN1;LAMA5;PPP2R5E;IFNAR1;MAPK3;PDGFB;HSP90B1;SOS1;RAB10;ITGB4;PPP2R5A;LAMC1;RAB14;PIK3CB;JAK1;IGF1R;THBS1;HSP90AA1;AKT1;GRB2;PTK2;KITLG;ITGB1;HIF1A;FOXA1;PIK3C2A;NRAS;MET;TBC1D1;EIF4B;CDC37;LAMB2;PFKFB3;EGFR;PDGFC
prerank,MAPK Signaling Pathway WP382,0.32967141,1.274034091,0.076923077,0.328866319,1,36/246,30.39%,IKBKG;JUND;RRAS2;AKT2;LAMTOR3;RASA1;TAB2;FLNA;MAPK3;MKNK2;PDGFB;MAP3K13;STK3;TGFBR2;SOS1;MAP2K4;MAPK8;STMN1;TAOK3;CRK;RPS6KA3;MAPK14;RAP1B;AKT1;GRB2;PPM1A;PRKACA;GNA12;PAK1;MAP3K2;MAP2K3;MAP3K14;NRAS;NF1;RAP1A;PPP3CA
prerank,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.452687749,1.272223421,0.148648649,0.329011503,1,30-Sep,40.01%,ERBB2;CTNNB1;TGFBR2;AKT1;NRAS;MET;EGFR;TGFB2;SMAD3
prerank,Histone Modifications WP2369,0.411114823,1.270910787,0.106666667,0.327503991,1,Jun-67,11.78%,H3F3B;SET;SETD5;SETD2;NSD1;ASH1L
prerank,Cell cycle WP179,0.378074255,1.267157165,0.160493827,0.330296928,1,22/120,37.91%,SKP1;YWHAZ;CDKN2A;ORC4;STAG2;YWHAQ;YWHAB;CDK4;ANAPC2;YWHAE;FZR1;HDAC2;ANAPC13;ANAPC7;CDC16;ANAPC5;ORC3;BUB3;TGFB2;ANAPC11;STAG1;CCND1
prerank,TNF-alpha signaling pathway WP231,0.36152019,1.258777081,0.137931034,0.343465461,1,22/92,33.90%,IKBKG;CSNK2A1;SKP1;TAB2;MAPK3;SOS1;MAP2K4;TBK1;MAPK8;HSP90AA1;AKT1;GRB2;OTUD7B;BID;TANK;MAP2K3;MAP3K14;FBXW11;NRAS;RFFL;CDC37;RAC1
prerank,Endochondral Ossification with Skeletal Dysplasias WP4808,0.458569371,1.253285152,0.2,0.346359635,1,Nov-64,44.69%,SLC38A2;IGF1R;AKT1;PRKACA;CALM1;STAT1;TGFB2;CHST11;SOX9;HMGCS1;CTSV
prerank,Endochondral Ossification WP474,0.458569371,1.253285152,0.2,0.346359635,1,Nov-64,44.69%,SLC38A2;IGF1R;AKT1;PRKACA;CALM1;STAT1;TGFB2;CHST11;SOX9;HMGCS1;CTSV
prerank,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.382922562,1.251616505,0.170731707,0.345113264,1,13/66,30.11%,MYL12B;GNAS;MAPK3;JAK1;MAPK14;IGF1R;RAP1B;AKT1;GNA12;CDK4;MAP2K3;STAT1;RAP1A
prerank,Hepatitis C and Hepatocellular Carcinoma WP3646,0.411590977,1.250163071,0.185185185,0.343892072,1,14/49,40.01%,UCHL1;MAPK3;SOS1;MAPK8;JAK1;MAPK14;AKT1;GRB2;HIF1A;RAC1;CCND1;CTTN;CASP3;SMAD3
prerank,NRF2 pathway WP2884,0.341513119,1.24900007,0.090909091,0.342341279,1,16/146,23.38%,FTH1;UGT1A6;PRDX6;SLC5A6;GPX3;MGST3;GCLM;PDGFB;TGFBR2;G6PD;HSP90AA1;GSR;SLC39A9;SLC7A11;ABCC3;GCLC
prerank,ATM Signaling Network in Development and Disease  WP3878,0.419413033,1.24632805,0.233766234,0.342924309,1,Jun-45,14.65%,IKBKG;TRIM28;PRKAA1;ATMIN;NBN;G6PD
prerank,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.396422519,1.243596124,0.189189189,0.345462707,1,Aug-70,27.44%,TUBA4A;UBE2J2;UBE2G1;PSMD8;PSMD9;PSMC3;PSMC6;PSMD5
prerank,Retinoblastoma gene in cancer WP2446,0.383696043,1.243126892,0.192307692,0.342910697,1,Sep-87,24.42%,SIN3A;RBBP7;DHFR;STMN1;CCDC6;RBBP4;PRMT2;CDK4;ZNF655
prerank,7q11.23 copy number variation syndrome WP4932,0.34847716,1.241313292,0.174418605,0.342790617,1,23/104,30.74%,BRD4;MYO1C;GTF2I;CTNNB1;DEK;MAPK3;SF3B1;BECN1;CFL1;ATPAF2;TSG101;UBE2E3;ATP5PB;GRB2;VPS37A;CLTC;OGDH;UBE2E1;SQSTM1;EIF2A;SMARCA5;HDAC2;TBL2
prerank,G13 Signaling Pathway WP524,0.387248732,1.240875243,0.12987013,0.340312665,1,Nov-39,39.48%,PPP1CB;DIAPH1;ROCK1;CFL1;PIK3CB;ARHGDIB;CALM1;RAC1;CFL2;TNK2;ROCK2
prerank,Senescence and Autophagy in Cancer WP615,0.344729596,1.228850783,0.209302326,0.358031893,1,12/105,18.08%,GABARAP;MMP14;FN1;CDKN2A;IFI16;BMI1;BECN1;PIK3C3;IL6ST;MAPK14;IGF1R;THBS1
prerank,IL-6 signaling pathway WP364,0.389944042,1.22740935,0.223529412,0.357001846,1,Oct-43,26.93%,SHC1;MAPK3;SOS1;MAP2K4;IL6ST;JAK1;AKT1;GRB2;STAT1;TYK2
prerank,Common Pathways Underlying Drug Addiction WP2636,0.450735292,1.224299073,0.194805195,0.357192808,1,Sep-42,30.86%,GNAS;ACTG1;PPP1CB;MAPK3;RAP1B;PRKACA;CALM1;RAP1A;ACTB
prerank,AMP-activated protein kinase (AMPK) signaling WP1403,0.382043649,1.222587683,0.210526316,0.356189358,1,Jul-69,19.26%,AKT2;PRKAA1;PIK3C3;ADIPOR1;PIK3CB;STRADB;AKT1
prerank,Apoptosis WP254,0.359662233,1.210156609,0.235294118,0.375587358,1,Oct-84,19.92%,IKBKG;SCAF11;CDKN2A;CASP2;BNIP3L;MAP2K4;IRF3;IGF1R;AKT1;BID
prerank,Ferroptosis WP4313,0.432308332,1.201923008,0.213333333,0.388044405,1,Aug-40,32.64%,FTH1;VDAC2;NCOA4;GCLM;SLC7A11;GCLC;SLC39A8;ACSL4
prerank,Amino Acid metabolism WP3925,0.336037007,1.193765088,0.206896552,0.39869854,1,Nov-91,26.98%,GLS;GCLM;ACADM;ACLY;CPS1;ODC1;LDHA;SDHA;GSR;MPST;OGDH
prerank,MET in type 1 papillary renal cell carcinoma WP4205,0.360358034,1.192715628,0.261904762,0.397989895,1,18/59,33.90%,RPL11;AKT2;PRCC;MAPK3;SOS1;STRN;MAPK8;CRK;PIK3CB;RAP1B;AKT1;GRB2;PTK2;PAK1;NRAS;RAP1A;MET;RAC1
prerank,IL-1 signaling pathway WP195,0.401409886,1.189890067,0.217948718,0.399156967,1,Dec-55,27.86%,IKBKG;TAB2;MAPK3;UBE2V1;MAP2K4;MAPK8;MAPK14;AKT1;MAP3K2;MAP2K3;MAP3K14;SQSTM1
prerank,Cytosolic DNA-sensing pathway WP4655,0.37031676,1.18492963,0.207792208,0.405844989,1,13/75,42.74%,IKBKG;POLR2F;TBK1;POLR2H;IRF3;POLR2E;TRIM25;POLR2L;ATG12;CYLD;POLR3F;POLR3C;ADAR
prerank,Endometrial cancer WP4155,0.357170182,1.181895568,0.219512195,0.408857113,1,Sep-63,19.36%,AKT2;ERBB2;CTNNB1;MAPK3;SOS1;CDH1;PIK3CB;AKT1;GRB2
prerank,Melanoma WP4685,0.353713044,1.173892004,0.225,0.421903903,1,15/68,29.99%,AKT2;LAMTOR3;CDKN2A;MAPK3;SOS1;CDH1;PIK3CB;AKT1;GRB2;VCL;CDK4;PAK1;CALM1;NRAS;NF1
prerank,AGE/RAGE pathway WP2324,0.375753421,1.170960515,0.25974026,0.4235288,1,16/66,40.52%,SHC1;MMP14;DIAPH1;ROCK1;MAPK3;MAPK8;MAPK14;AKT1;HIF1A;STAT1;RAC1;EGFR;ATF2;CASP3;SMAD3;DDOST
prerank,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.385699479,1.165323774,0.225,0.43167137,1,Sep-49,27.26%,TAB2;MAPK3;MKNK2;MAP2K4;MAPK8;MAPK14;TANK;MAP2K3;MAP3K14
prerank,Interleukin-11 Signaling Pathway WP2332,0.373839918,1.163828609,0.307692308,0.43131933,1,Oct-44,26.93%,PIAS1;MAPK3;YES1;IL6ST;FYN;JAK1;AKT1;GRB2;STAT1;TYK2
prerank,Type 2 papillary renal cell carcinoma WP4241,0.390306723,1.152848351,0.266666667,0.448723075,1,Jun-34,16.21%,DIAPH1;PRCC;PDGFB;EGLN3;SETD2;ELOB
prerank,Androgen receptor signaling pathway WP138,0.307990073,1.15007934,0.231707317,0.449397772,1,Dec-90,12.26%,CAV1;RACK1;ROCK1;CTNNB1;NCOA4;PIAS1;FLNA;SIN3A;SMARCE1;RNF6;RNF14;TGIF1
prerank,Notch Signaling WP268,0.368090553,1.149438667,0.293333333,0.447662961,1,Jul-45,16.28%,LFNG;ADAM17;DVL1;DTX4;NUMBL;RBPJ;DVL3
prerank,Signaling of Hepatocyte Growth Factor Receptor WP313,0.398794788,1.142097397,0.277108434,0.458994115,1,Dec-34,32.51%,RASA1;MAPK3;SOS1;MAPK8;CRK;RAP1B;GRB2;PTK2;ITGB1;PAK1;RAP1A;MET
prerank,Electron Transport Chain (OXPHOS system in mitochondria) WP111,-0.235135547,-1.132694316,0.166666667,0.836623889,1,11/103,9.48%,NDUFA1;COX5B;ATP5ME;NDUFB7;ATP5F1E;ATP5IF1;NDUFB2;COX7C;NDUFA2;COX5A;NDUFS7
prerank,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.39404469,1.122077381,0.337662338,0.49440642,1,May-37,20.01%,CHD4;H3F3B;RBBP7;MTA3;RBBP4
prerank,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.378156668,1.117393506,0.341463415,0.499567304,1,Jul-42,19.67%,AKT2;CTNNB1;MAPK3;MAPK8;MAPK14;AKT1;TNFRSF12A
prerank,Pathways in clear cell renal cell carcinoma WP4018,0.324869322,1.110044192,0.34939759,0.50919998,1,18/85,39.81%,ENO1;TPI1;PDGFB;SETD2;ACLY;PGM2;BAP1;LDHA;AKT1;PLOD2;HIF1A;SQSTM1;ME1;BHLHE41;EGFR;TGFB2;GAPDH;KDM5C
prerank,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.355133596,1.097191729,0.371794872,0.528454685,1,Aug-60,22.25%,DDX3X;IKBKG;AZI2;TBK1;MAPK8;IRF3;MAPK14;TANK
prerank,Integrin-mediated Cell Adhesion WP185,0.310543108,1.092243452,0.344827586,0.534512316,1,17/101,26.27%,CAV1;SHC1;AKT2;ROCK1;CAPNS1;SOS1;ITGB4;CRK;FYN;RAP1B;AKT1;GRB2;PTK2;ITGB1;VCL;PAK1;MAP2K3
prerank,Proteasome Degradation WP183,0.311078677,1.090398067,0.376470588,0.533850148,1,Dec-62,23.00%,PSMA5;UBE2D3;UBB;UCHL1;PSMD8;UBE2D2;PSMD9;PSMC3;UBE2D1;RPN2;PSMC6;UBE2B
prerank,Fatty acid beta-oxidation WP143,0.366582478,1.09028866,0.317073171,0.529955121,1,Sep-34,40.93%,TPI1;ACADM;HADHA;ACADVL;HADHB;ACSL4;CPT2;DLD;GPD2
prerank,Oxidative phosphorylation WP623,-0.258083304,-1.088972712,0.357142857,0.76875617,1,Jul-60,9.48%,ATP5ME;NDUFA11;NDUFB7;ATP5F1E;NDUFB2;NDUFA2;NDUFS7
prerank,16p11.2 distal deletion syndrome WP4950,0.390279327,1.080584653,0.361111111,0.543909713,1,Apr-31,9.39%,C3;RAB5A;CD81;ATXN2L
prerank,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.373220999,1.079878924,0.351351351,0.541417268,1,Sep-71,28.89%,CAV1;MAPK3;SP3;MAPK8;JAK1;MAPK14;STAT1;TYK2;NRAS
prerank,IL-4 signaling pathway WP395,0.358607822,1.07890408,0.342465753,0.539314285,1,Oct-54,26.93%,SHC1;FLNA;MAPK3;SOS1;JAK1;MAPK14;AKT1;GRB2;STAT1;TYK2
prerank,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.35997962,1.075652357,0.358024691,0.541962779,1,16/46,47.55%,FADS2;DHCR24;EBP;GGPS1;DHCR7;SOAT1;ACSL4;MVD;FDFT1;CYP51A1;FDPS;SQLE;HMGCS1;LBR;NSDHL;MSMO1
prerank,ESC Pluripotency Pathways WP3931,0.329499054,1.074681629,0.364705882,0.53953963,1,13/116,28.03%,AKT2;CTNNB1;DVL1;PDGFB;SOS1;IL6ST;DVL3;JAK1;AKT1;GRB2;MAP2K3;ACTR2;FZD6
prerank,Nonalcoholic fatty liver disease WP4396,-0.212815017,-1.073056003,0.25,0.667818361,1,14/155,10.28%,NDUFA13;NDUFA1;COX5B;NDUFA11;NDUFB7;COX7B2;AKT3;PIK3CA;NDUFB2;COX7C;NDUFA2;COX5A;NDUFS7;NR1H3
prerank,Calcium Regulation in the Cardiac Cell WP536,0.328581732,1.072368919,0.384615385,0.540252796,1,9/150,26.34%,GNAS;YWHAZ;FKBP1A;YWHAQ;ATP2A2;YWHAB;PRKACA;CALM1;YWHAE
prerank,Cytoplasmic Ribosomal Proteins WP477,0.283506175,1.064461993,0.414893617,0.551901297,1,17/89,17.18%,RPL32;RPL11;RPL8;RPL37;RPL17;RPL15;RPL29;RPL13;RPL4;RPL22;RPSA;RPLP0;RPS20;RPS27;RPL41;RPS6KA3;RPL28
prerank,ATM Signaling Pathway WP2516,0.386736321,1.062697299,0.373134328,0.552345473,1,Apr-40,10.78%,IKBKG;CASP2;TLK1;NBN
prerank,Mesodermal commitment pathway WP2857,0.291552734,1.053263325,0.426829268,0.567450015,1,16/147,31.01%,TRIM28;PIAS1;TEAD1;SETD2;PHF6;DKK1;CUL4B;CCDC6;PARP8;PRKACA;YAP1;AHDC1;FOXA1;CTBP2;TEAD2;AEBP2
prerank,Chemokine signaling pathway WP3929,0.301526422,1.052715417,0.402298851,0.564597258,1,17/164,30.75%,SHC1;IKBKG;AKT2;ROCK1;MAPK3;SOS1;CRK;PIK3CB;RAP1B;AKT1;GRB2;PTK2;PAK1;STAT1;NRAS;RAP1A;LYN
prerank,Autophagy WP4923,0.358413552,1.046918649,0.385542169,0.571341668,1,30-Mar,13.61%,PRKAA1;BECN1;PIK3C3
prerank,Notch Signaling Pathway Netpath WP61,0.3495382,1.043468706,0.441558442,0.573452981,1,Dec-61,37.91%,SKP1;ADAM17;NUMBL;RBPJ;AKT1;HIF1A;NCOR1;NUMB;ITCH;HDAC2;NCOR2;CCND1
prerank,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.310508743,1.04272791,0.407407407,0.571191619,1,Jul-73,13.83%,AKT2;CTNNB1;MAPK3;TGFBR2;CSNK1A1;TBK1;MAPK8
prerank,Rett syndrome causing genes WP4312,0.343963889,1.042583768,0.459459459,0.56765929,1,Aug-48,28.17%,CHD4;TBL1XR1;CRK;GPS2;NCOR1;TRRAP;SMARCA1;SYNGAP1
prerank,Nanoparticle-mediated activation of receptor signaling WP2643,0.357426627,1.04204458,0.4,0.56449866,1,28-Aug,28.89%,FN1;SOS1;MAPK8;MAPK14;GRB2;PTK2;ITGB1;NRAS
prerank,Amyotrophic lateral sclerosis (ALS) WP2447,0.352239106,1.029997816,0.415584416,0.583296807,1,Sep-38,44.26%,RAB5A;MAPK14;DERL1;BID;PPP3CA;RAC1;CASP3;BAX;CAT
prerank,16p11.2 proximal deletion syndrome WP4949,0.305749456,1.028964606,0.460526316,0.581508461,1,Sep-74,17.65%,MAZ;PPP4R3B;PARP4;TMEM219;MAPK3;CCT3;BPTF;CCDC6;PPP4R2
prerank,Neovascularisation processes WP4331,0.37432048,1.025077676,0.425,0.585446522,1,Jun-37,24.26%,MAPK3;PDGFB;MAPK8;AKT1;KITLG;HIF1A
prerank,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.351918524,1.024196376,0.526315789,0.583116985,1,Oct-66,33.08%,LARP1;IFNAR1;TBK1;AP1G1;IRF3;JAK1;TANK;STAT1;HDAC2;TRIM25
prerank,miRNA regulation of DNA damage response WP1530,0.332252801,1.023219036,0.453333333,0.581599814,1,Dec-71,39.96%,TLK1;NBN;TLK2;BID;CDK4;RFC1;PML;CCNG1;RAD1;CCND1;CASP3;BAX
prerank,Aryl Hydrocarbon Receptor Netpath WP2586,0.357926541,1.01845382,0.414634146,0.58763338,1,Aug-46,35.62%,AHR;HSP90AA1;GCLC;NRAS;NF1;CDC37;NCOR2;EGFR
prerank,Pancreatic adenocarcinoma pathway WP4263,0.28197178,1.01079532,0.475,0.597444548,1,14/89,27.75%,IKBKG;AKT2;ERBB2;CDKN2A;MAPK3;TGFBR2;MAPK8;PIK3CB;JAK1;AKT1;CDK4;PAK1;STAT1;RALBP1
prerank,G Protein Signaling Pathways WP35,0.328498634,1.004567406,0.518518519,0.605825612,1,Oct-93,30.39%,GNAS;PRKCI;AKAP11;PRKACA;AKAP10;GNA12;CALM1;NRAS;PRKD3;PPP3CA
prerank,Integrated breast cancer pathway WP1984,0.264133848,0.985540407,0.574712644,0.635949051,1,22/152,30.13%,CSNK1D;PPP4R3B;AHR;CTNNB1;UBE2F;PIAS1;TPR;MAP3K13;TGFBR2;CDH1;JAK1;ODC1;AKT1;BID;CDK4;ZNF655;PAK1;STAT1;PML;NF1;RAP1A;PHB
prerank,DNA damage response WP707,0.315926823,0.984944489,0.448717949,0.632628916,1,Nov-68,39.96%,TLK1;NBN;TLK2;BID;CDK4;RFC1;PML;RAD1;CCND1;CASP3;BAX
prerank,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.347475816,0.981627022,0.506666667,0.634462252,1,Sep-50,34.12%,AKT2;PRKAA1;MAPK3;PIK3CB;AKT1;SYNGAP1;NRAS;NF1;UBE3A
prerank,Proximal tubule transport WP4917,-0.290712371,-0.970584456,0.526315789,0.834155972,1,Apr-57,13.63%,ATP1A1;ATP6V1G1;SLC9A3;ATP6V1D
prerank,Phosphoinositides metabolism WP4971,0.327059899,0.967568901,0.448717949,0.655542045,1,Sep-49,37.30%,PLCD3;PIK3C3;PIK3CB;MTMR2;MTMR6;PIK3C2A;OCRL;MTMR1;PLCG1
prerank,Netrin-UNC5B signaling pathway WP4747,0.318765494,0.967391103,0.530120482,0.651790234,1,Aug-52,21.72%,NTN4;MAPK3;ITGB4;FYN;MAPK14;AKT1;PTK2;YAP1
prerank,Non-small cell lung cancer WP4255,0.292876864,0.967101948,0.56097561,0.648011565,1,17/72,39.96%,AKT2;ERBB2;CDKN2A;MAPK3;SOS1;PIK3CB;AKT1;GRB2;BID;CDK4;NRAS;EGFR;EML4;PLCG1;CCND1;CASP3;BAX
prerank,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.342211779,0.964573789,0.4875,0.648017978,1,May-36,17.44%,MAPK3;MAP2K4;MAPK8;RPS6KA3;MAPK14
prerank,Spinal Cord Injury WP2431,0.281530267,0.96368291,0.438356164,0.646494579,1,17/118,46.74%,RHOC;FKBP1A;MAPK3;CDK4;PTPRA;CCNG1;PPP3CA;RAC1;EGFR;CCND1;CHST11;CASP3;ROCK2;SOX9;ZFP36;CD47;RTN4
prerank,Regulation of toll-like receptor signaling pathway WP1449,0.273009361,0.9596918,0.581395349,0.650926472,1,16/139,27.86%,IKBKG;AKT2;TAB2;IFNAR1;MAPK3;MAP2K4;TBK1;MAPK8;IRF3;PIK3CB;MAPK14;AKT1;TMED7;MAP2K3;STAT1;SQSTM1
prerank,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.3163246,0.958968052,0.512820513,0.648828267,1,May-44,14.31%,PRKAA1;GTPBP2;BECN1;PIK3C3;PANK2
prerank,IL-18 signaling pathway WP4754,0.236457043,0.957197721,0.542553191,0.647971335,1,13/272,9.66%,NACA;ITM2C;PRKAA1;MEPCE;MMP14;FN1;CD81;CTNNB1;PRCC;DEK;ENO1;MAPK3;B2M
prerank,Target Of Rapamycin (TOR) Signaling WP1471,0.324576379,0.940303863,0.578947368,0.676484555,1,May-36,24.95%,PRKAA1;FKBP1A;RICTOR;AKT1;MAPKAP1
prerank,Adipogenesis WP236,-0.209118639,-0.927683396,0.75,0.82745734,1,8/130,10.28%,MEF2D;CISD1;BMP1;GADD45A;BSCL2;SPOCK1;KLF15;NR1H3
prerank,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.316608429,0.921563047,0.56097561,0.704585636,1,Jul-47,19.26%,MAPK3;YES1;MAPK8;FYN;JAK1;MAPK14;AKT1
prerank,Modulators of TCR signaling and T cell activation WP5072,0.310774707,0.904152314,0.6,0.730315138,1,Aug-61,22.65%,DGKZ;IKBKG;CUL5;ELOB;BCL10;AKT1;GRB2;RPRD1B
prerank,Thyroid hormones production and their peripheral downstream signaling effects WP4746,-0.200927244,-0.899081765,0.588235294,0.791892892,1,Oct-95,18.37%,AKT3;PIK3CA;TSC2;PAX8;MAP2K1;BAD;TP53;SIRT6;DIO2;MAPK1
prerank,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.27503963,0.898619549,0.614457831,0.737305758,1,Nov-50,39.96%,CDKN2A;MAP2K4;MAPK8;MAPK14;HSP90AA1;BID;MAP2K3;EGFR;ATF2;CCND1;BAX
prerank,Joubert Syndrome WP4656,0.28507297,0.897781801,0.613333333,0.734287579,1,Apr-76,7.92%,TCTN1;TCTN3;DVL1;FLNA
prerank,Metabolic reprogramming in colon cancer WP4290,0.298996914,0.888206132,0.641025641,0.746279987,1,Jul-42,27.31%,GLS;ENO1;ACLY;G6PD;LDHA;SDHB;TKT
prerank,Vitamin D Receptor Pathway WP2877,0.269391226,0.88733241,0.654320988,0.743107508,1,10/182,26.67%,CDKN2A;TIMP2;CLPTM1L;SERPINB1;KLK6;G6PD;CD9;LPGAT1;HIF1A;MYO9B
prerank,Glucocorticoid Receptor Pathway WP2880,0.303085253,0.873119012,0.653333333,0.76057195,1,Sep-70,34.14%,ABHD2;KTN1;ENC1;DNAJC15;HSP90AA1;ARL5B;PTGES3;LRRC8A;CDC42EP3
prerank,Fas ligand pathway and stress induction of heat shock proteins WP314,0.282302164,0.872610645,0.6125,0.757014695,1,Sep-42,30.86%,ACTG1;MAP2K4;MAPK8;LMNA;ARHGDIB;PAK1;RIPK2;DFFA;ACTB
prerank,Neural Crest Differentiation WP2064,0.285455885,0.869581053,0.631578947,0.758218416,1,8/101,30.66%,CTNNB1;DVL1;RBPJ;CDH1;DVL3;ITGB1;CTBP2;HDAC2
prerank,DNA Repair Pathways Full Network WP4946,0.246390547,0.853322459,0.642857143,0.781333813,1,18/120,40.83%,XRCC6;NBN;CUL4B;MNAT1;GTF2H1;MPG;XRCC4;FANCL;POLM;RFC1;MBD4;CUL4A;RAP1A;ERCC5;RPA1;RAD23B;NHEJ1;TDG
prerank,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.307316372,0.852864276,0.684931507,0.777252853,1,May-37,24.26%,BNIP3L;SLC16A1;LDHA;BID;HIF1A
prerank,miRNA regulation of prostate cancer signaling pathways WP3981,0.278222486,0.833137929,0.706666667,0.806233476,1,Apr-33,19.36%,IKBKG;CTNNB1;SOS1;GRB2
prerank,Copper homeostasis WP3286,0.282620867,0.826594215,0.708333333,0.811222761,1,Feb-52,3.93%,APP;ADAM17
prerank,Genes related to primary cilium development (based on CRISPR) WP4536,0.242320928,0.813630514,0.7875,0.828744132,1,13/103,39.88%,TCTN1;HSPB11;TCTN3;IFT57;TULP3;TRAF3IP1;IFT52;IFT74;OFD1;KIAA0753;LZTFL1;DYNLL1;BBS10
prerank,One-carbon metabolism and related pathways WP3940,0.255779135,0.805862347,0.731707317,0.835966238,1,Jun-52,23.38%,GPX3;GCLM;AHCYL1;PEMT;GSR;GCLC
prerank,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.272438267,0.801430538,0.753246753,0.838051493,1,Apr-47,13.83%,PPP1CB;PPP1R12A;PPP1R7;MAPK8
prerank,Bladder cancer WP2828,0.253404534,0.769410461,0.7625,0.878676143,1,Aug-40,37.91%,ERBB2;CDKN2A;CDH1;THBS1;CDK4;NRAS;EGFR;CCND1
prerank,p53 transcriptional gene network WP4963,0.275522159,0.759125116,0.797468354,0.888844137,1,Sep-67,41.60%,THBS1;SLC7A11;TRAF4;PML;CCNG1;ERCC5;NCF2;BAX;LIF
prerank,Energy Metabolism WP1541,0.24719027,0.7586926,0.753424658,0.884549879,1,Feb-47,3.31%,PRKAA1;GABPA
prerank,Eukaryotic Transcription Initiation WP405,0.238133527,0.749193201,0.8375,0.889882017,1,Jul-43,35.66%,POLR2F;POLR2H;MNAT1;GTF2H1;POLR2B;POLR2E;GTF2A2
prerank,Pyrimidine metabolism WP4022,-0.164115611,-0.738427786,0.928571429,0.985521553,1,27/85,74.28%,ZNRD1;NT5C;POLR2I;DUT;POLR2A;CTPS2;POLR1C;POLR2C;NME3;POLE4;POLR2J3;UCK1;POLR3D;POLD4;NME1-NME2;POLR3H;UCKL1;POLE2;CTPS1;POLD3;POLR1D;POLR3C;POLR3F;POLR2L;POLR2E;POLR2B;NME2
prerank,Selenium Micronutrient Network WP15,0.225269643,0.731040584,0.821917808,0.907147248,1,Jun-89,30.53%,GPX3;SELENOF;KYNU;GSR;SELENOT;GPX2
prerank,p38 MAPK Signaling Pathway WP400,0.232445854,0.716888751,0.864864865,0.919207187,1,Oct-34,38.58%,SHC1;MAP2K4;MAPK14;GRB2;STAT1;RAC1;MAPKAPK5;TGFB2;ATF2;MKNK1
prerank,Ectoderm Differentiation WP2858,0.201135231,0.716096661,0.882352941,0.915842171,1,20/138,49.10%,NUMA1;CTNNB1;WDR44;STX16;FYN;UBTF;TRIM33;OGT;SGSM3;BAZ1A;CAP2;LY6E;SKIL;SERPINB6;TCF3;RIT1;PHF8;HDAC10;PPARD;ZBTB7B
prerank,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.21422834,0.697072012,0.829268293,0.933754022,1,Apr-46,12.31%,PLEC;MAPK3;SOS1;CFL1
prerank,Nucleotide Excision Repair WP4753,0.215255595,0.669109239,0.888888889,0.958212802,1,Aug-44,37.61%,CUL4B;MNAT1;GTF2H1;RFC1;CUL4A;ERCC5;RPA1;RAD23B
prerank,3q29 copy number variation syndrome WP4906,0.221633311,0.656047702,0.92,0.963547813,1,Sep-63,39.54%,DLG1;AKT1;HFE;HIF1A;PIGX;SENP5;MELTF;ADAM10;DYNLL1
prerank,Folate Metabolism WP176,0.213208279,0.626152328,0.906666667,0.979527748,1,Mar-69,14.67%,GPX3;DHFR;AHCY
prerank,Ciliopathies WP4803,-0.140661433,-0.624966488,0.9375,0.970384995,1,6/183,9.93%,B9D2;B9D1;BBS7;GAS8;XPNPEP3;ADCY6
prerank,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.206683361,0.617656636,0.917808219,0.979405775,1,May-32,30.66%,CDK9;NELFB;SUPT4H1;PPP3CA;HDAC2
prerank,Glycolysis and Gluconeogenesis WP534,0.203083977,0.569842466,0.932432432,0.999013574,1,Nov-45,52.45%,ENO1;TPI1;LDHA;FBP1;DLD;GAPDH;MDH1;PDHA1;ALDOA;PC;PFKM
prerank,Apoptosis Modulation and Signaling WP1772,0.171329458,0.568051368,0.953488372,0.994819689,1,Apr-90,8.36%,CDKN2A;CASP2;CAPNS1;MAPK3
prerank,CAMKK2  Pathway WP4874,0.188010626,0.553729565,1,0.994981364,1,Jun-34,34.56%,MAPK3;DNM1L;CALM1;SQSTM1;RAC1;ARHGEF7
prerank,Alzheimer's disease WP2059,0.171130498,0.543160971,0.987341772,0.994068607,1,Mar-83,8.36%,APP;ADAM17;MAPK3
prerank,Genotoxicity pathway WP4286,0.182619341,0.512511257,0.987012987,0.995655644,1,Apr-63,24.66%,DAAM1;RPS27;EI24;TM7SF3
prerank,G1 to S cell cycle control WP45,0.16343657,0.457726061,1,0.99763984,1,Oct-64,46.27%,CDKN2A;ORC4;MNAT1;CDK4;RPA1;ORC3;CCND1;TFDP2;CCNB1;CREB1